1Xiang YZ,Xia Y,Gao XM,et al.Platelet activation,and antiplatelet targets and agents:current and novel strategies[J].Drugs,2008,68(12):1647-1664.
2Jennings LK,Saucedo JF.Antiplatelet and anticoagulant agents:key differences in mechanisms of action,clinical application,and therapeutic benefit in patients with non-ST-segment-elevation acute coronary syndromes[J].Curr Opin Cardiol,2008,23(4):302-308.
3Gawaz M,Langer H,May AE.Platelets in inflammation and atherogenesis[J].J Clin Invest,2005,115(12):3378-3384.
4Hofer CK,Zollinger A,Ganter MT.Perioperative assessment of platelet function in patients under antiplatelet therapy[J].Expert Rev Med Devices,2010,7(5):625-637.
5Rovellini A,Folli C,Cardani F,et al.Thromboembolic and haemorrhagic events in permanent atrial fibrillation:observational study in an emergency department[J].Eur J Intern Med,2009,20(8):756-759.
6Harrison P.Progress in the assessment of platelet function[J].Br J Haematol,2000,111(3):733-744.
7Madsen EH,Saw J,Kristensen SR,et al.Long-term aspirin and clopidogrel response evaluated by light transmission aggregometry,VerifyNow,and thrombelastography in patients undergoing percutaneous coronary intervention[J].Clin Chem,2010,56(5):839-847.
8Zhou L,Schmaier AH.Platelet aggregation testing in platelet-rich plasma:description of procedures with the aim to develop standards in the field[J].Am J Clin Pathol,2005,123(2):172-183.
9Breet NJ,van Werkum JW,Bouman HJ,et al.Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation[J].JAMA,2010,303(8):754-762.
10Jakubowski JA,Li YG,Small DS,et al.A comparison of the VerifyNow P2Y12 point-of-care device and light transmission aggregometry to monitor platelet function with prasugrel and clopidogrel:an integrated analysis[J].J Cardiovasc Pharmacol,2010,56(1):29-37.
